Annette Bayer

Title: Annette Bayer: Innovator in Antimicrobial Compounds

Introduction

Annette Bayer is a prominent inventor based in Tromsø, Norway. She has made significant contributions to the field of bioactive compounds, particularly in the development of antimicrobial agents. With a total of 2 patents, her work focuses on innovative solutions to combat bacterial infections.

Latest Patents

Annette Bayer's latest patents include groundbreaking inventions. One of her notable patents is for "Barbituric acid derivatives comprising cationic and lipophilic groups." This invention relates to bioactive cyclic compounds and their use as antimicrobial agents. Specifically, it involves barbiturate mimics of Eusynstyelamides or small antimicrobial peptides. The compounds are represented by a specific formula that showcases their unique properties.

Another significant patent is for "Inhibitors of metallo-beta-lactamase (MBL) comprising a zinc chelating moiety." This invention provides compounds that are designed to interact with biological structures found in bacteria, such as penicillin-binding proteins. The method of treating and preventing bacterial infections in humans and non-human mammals using these compounds is also outlined in this patent.

Career Highlights

Throughout her career, Annette Bayer has worked with esteemed institutions, including the University of Oslo and the Arctic University of Norway in Tromsø. Her research has focused on developing innovative solutions to address pressing health challenges related to bacterial infections.

Collaborations

Annette has collaborated with notable colleagues, including Pål Rongved and Ove Alexander Høgmoen Åstrand. These partnerships have contributed to her success in the field of antimicrobial research.

Conclusion

Annette Bayer's contributions to the development of antimicrobial compounds highlight her innovative spirit and dedication to improving health outcomes. Her patents reflect a commitment to addressing critical challenges in medicine.